期刊文献+

分次经尿道膀胱肿瘤电切术加化疗治疗高危晚期膀胱癌的临床分析 被引量:1

Clinical Analysis of the TURBT and Chemotherapy in Treatment of Elderly Bladder Carcinoma
下载PDF
导出
摘要 目的分析分次经尿道膀胱肿瘤电切术加化疗治疗高危晚期膀胱癌的临床疗效。方法随机抽取高危晚期膀胱癌患者21例,采取分次经尿道膀胱肿瘤电切术加化疗治疗。结果 21例患者近期疗效总有效率57.1%,1例患者术后7个月因合并症死亡,术后排尿困难、尿失禁、血尿等症状改善明显,未发生严重并发症,其余患者至今存活。结论分次经尿道膀胱肿瘤电切术加化疗治疗高危晚期膀胱癌效果显著。 Objective To analyze the clinical effect of transurethral resection of bladder tumor and chemotherapy in the treatment of high risk patients with advanced bladder cancer.Methods 21 patients with advanced bladder cancer were randomly selected and treated with transurethral resection of bladder tumor.ResultsThe total effective rate was 57.1% in 21 patients,and 1 patients died after surgery for 7 months. The symptoms improved obviously, such as difficulty of urination,incontinence of urine,hematuria and so on.Conclusion Transurethral resection of bladder tumor with transurethral resection of bladder tumor in high risk patients with advanced bladder cancer.
作者 罗钢
机构地区 吉林市人民医院
出处 《中国卫生标准管理》 2015年第20期37-38,共2页 China Health Standard Management
关键词 经尿道膀胱肿瘤电切术 高危晚期膀胱癌 化疗 TURBT Elderly bladder carcinoma Chemotherapy
  • 相关文献

参考文献3

二级参考文献17

  • 1罗宏,周宏,李元,王传麟,刘南,朱葆捷,毛林.经尿道膀胱肿瘤电切术(TURBT)治疗浸润性膀胱癌[J].现代肿瘤医学,2006,14(11):1423-1424. 被引量:14
  • 2徐子强,赵英奇,范玉铃.经尿道深切除治疗浸润性膀胱癌疗效观察[J].天津医药,2007,35(1):69-70. 被引量:8
  • 3Shipley WU, Kaufman DS, Zehr E, et al. Selective bladder pres- ervation by combined modality protocol treatment: long-term out- comes of 190 patients with invasive bladder cancer[ J]. Urology, 2002,60( 1 ) :62-68.
  • 4Winquist E, Kirchner TS, Segal R, et al. Neoadjuvant chemother- apy for transitional cell carcinoma of the bladder: a systematic re- view and meta-analysis[ J]. J Urol, 2004,171 (2 Pt 1 ) :561-569.
  • 5Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and recta-analysis of individual patient data ad- vanced bladder cancer ( ABC ) meta-analysis collaboration [ J ]. Eur Urol, 2005,48(2) :202-206.
  • 6Malmstrom PU, Rintala E, Wahlqvist R, et al. Five-year followup of a prospective trial of radical cysteetomy and neoadjuvant chemo- therapy: Nordic Cystectomy Trial I. The Nordic Cooperative Blad- der Cancer Study Group [ J ]. J Urol, 1996,155 (6) : 1903-1906.
  • 7Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemo- therapy plus cystectomy compared with eystectomy alone for locally ad- vanced bladder cancer[J]. N Engl J Med, 21303,349(9) :859-866.
  • 8Juffs HG, Moore MJ, Tannoek IF. The role of systemic chemother- apy in the management of musele-invasive bladder cancer [ J ]. Lancet Oncol, 2002,3 (12) :738-747.
  • 9Kilani RT, Tamimi Y, Karmali S, et al. Selective cytotoxicity of gemcitabine in bladder cancer cell lines [ J ]. Anticancer Drugs, 2002,13 (6) :557-566.
  • 10Roberts JT, yon der Maase H, Sengelov L, et al. Long-term sur- vival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer [ J ]. Ann Oneol, 2006,17 ( Suppl 5 ) : 118-122.

共引文献26

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部